Cash Flow Statement

Growth Metrics

EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)

Others

Ratios

Innate Pharma (IPHYF) EBIT Margin Growth (1y) (2022 - 2025)